MaaT Pharma financial statements
MaaT Pharma's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | EUR 4.52M | EODHD |
| Net income | −EUR 31.06M | EODHD |
| Cash and equivalents | EUR 24.87M | EODHD |
| Total debt | EUR 17.44M | EODHD |